News

NEWS
Education
June 2, 2021
InSysBio's student to defend diploma thesis
Elena Vasileva, student of Lomonosov Moscow State University (MSU) has developed her diploma thesis in InSysBio and successfully passed its defense. Her diploma thesis entitled “Optimization of anti-CD47 therapeutic agent dosage using PK/PD modeling” was supervised by Oleg Demin Jr, Head of Oncology and Immuno-Oncology at InSysBio.
LEARN MORE
NEWS
Press-Release
May 19, 2021
InSysBio to upgrade its SbmlViewer application
[Moscow – 19.05.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, launches the new version (0.3.0) of its SbmlViewer open project. Generally, SbmlViewer is a tool for fast and easy reading and transformation of biological models written in SBML format.
LEARN MORE
NEWS
Press-Release
April 6, 2021
InSysBio to present Heta compiler version 0.6
InSysBio presents the major updates of Heta compiler. Heta compiler is a software tool for development of QSP modeling platforms. In fact, its core option is the compilation of Heta-based platforms. Its functionality has been significantly elaborated and now Heta compiler has become even more useful and functional.
LEARN MORE
NEWS
Press-Release
March 30, 2021
InSysBio to launch Immune Response Template 3.4.0
IRT gets new data and recalculated parameters [Moscow – 30.03.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, launches Immune Response Template (IRT) version 3.4.0. IRT represents a Quantitative Systems Pharmacology (QSP) platform of immune system simultaneously being a tool for development of models related to immune system. IRT is based on two main components.
LEARN MORE
NEWS
Press-Release
February 15, 2021
InSysBio to be interviewed in frames of INNOVATORS VS COVID-19 series
[Moscow – 15.02.2021] Oleg Demin Jr, Head of Oncology and Immuno-Oncology at InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, has talked to startup.info, a global innovation ecosystem magazine. The interview in frames of the series "INNOVATORS VS COVID-19" covers the application of system-pharmacology modeling to different stages of drug research and development and InSysBio's current development in the context of the pandemic.
LEARN MORE
NEWS
Press-Release
January 26, 2021
InSysBio to announce the upgrade of its SbmlViewer application to version 0.2.7
[Moscow – 26.01.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, launces the new version of its SbmlViewer open project. Generally, SbmlViewer represents a tool for fast and easy reading of biological models written in SBML format.
LEARN MORE
March 2022
MoTuWeThFrSaSu
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
1. 17 Mar 2022 14:17 InSysBio to present posters at AACR Annual Meeting 2022 InSysBio team is going to present its posters in frames of American Association for Cancer Research (AACR) Annual Meeting 2022 which is to be held April 8-13, New Orleans, Louisiana. The abstracts have been published on AACR website and E-Posters are going to be presented if frames of Poster Sessions
18
19
20
21
22
23
24
25
26
27
28
29
1. 29 Mar 2022 13:44 InSysBio to take part in QSPC2022 InSysBio announces its participation in Quantitative Systems Pharmacology Conference 2022 (QSPC2022) which is to be held on April 20-22, 2022, Leiden, The Netherlands. InSysBio team is going to present its QSP tools at the Booth and 15 posters in frames of the Conference
30
31
   
Upcoming Events
25.06
InSysBio to hold a workshop on IRT at PAGE 2024
Tags